Stem Cell Therapy for Back Pain and Disc Degeneration in Colombia

Chronic low back pain affects approximately 80% of adults at some point in their lives, and degenerative disc disease is among the most common causes. For patients who have failed conservative management (physical therapy, medications, epidural steroid injections) but are not candidates for — or want to avoid — spinal surgery, mesenchymal stem cell therapy represents an emerging treatment option with a growing but still developing evidence base.

How MSC Therapy Addresses Disc Degeneration

Intervertebral discs have notoriously poor blood supply, which limits their natural healing capacity. MSC injections aim to change the biochemical environment within the disc — reducing inflammatory mediators, delivering growth factors that may stimulate disc cell activity, and potentially slowing the degenerative process. Published research suggests MSCs can reduce intradiscal inflammation, improve disc hydration (visible on follow-up MRI in some studies), slow further degeneration in early-to-moderate disease, and reduce pain through both anti-inflammatory and possible structural mechanisms.

Who Is a Good Candidate?

The best candidates for MSC disc therapy are patients with single or double-level disc degeneration confirmed on MRI (Pfirrmann Grade 2-4), discogenic pain (pain originating from the disc itself, not from nerve compression), failure of at least six months of conservative treatment, and no significant spinal instability or structural nerve compression requiring surgical decompression.

Treatment Protocol and Pricing

Treatment typically involves a two to three-day process. Day one includes clinical evaluation and MRI review (recent imaging required — within three to six months). Day two is the injection procedure, performed under fluoroscopic (live X-ray) guidance to ensure precise placement into the disc nucleus. The procedure takes approximately 45–90 minutes under local anesthesia with IV sedation. Some protocols include a simultaneous facet joint injection if those joints are also contributing to pain.

Recovery and Results Timeline

Recovery from intradiscal MSC injection is relatively straightforward compared to spinal surgery. Most patients experience mild soreness at the injection site for two to five days. Activity restrictions are modest: avoid heavy lifting and high-impact exercise for four to six weeks. Return to normal daily activities occurs within one to two weeks for most patients.

Results develop gradually. Weeks one to four may involve some inflammation as the cells begin their work. Months one to three bring the first noticeable improvements for most responders. Months three to twelve see continued improvement as disc remodeling progresses. Follow-up MRI at six to twelve months can document changes in disc hydration and structure.